One-Month Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation: The REIWA Region-Wide Registry

One-Month Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation: The REIWA Region-Wide Registry

Single-agent antiplatelet therapy with a P2Y12 inhibitor after one month of dual antiplatelet therapy (DAPT) is safe and feasible in Japanese patients undergoing biodegradable polymer DES (BP-DES) implantation in coronary arteries from the REIWA registry, Dr. Masaru Ishida and colleagues, Iwate Medical University, Japan, reported in the June issue of the Circulation Journal.

The safety and feasibility using 1-month dual antiplatelet therapy (DAPT) followed by P2Y12 inhibito...
Continue reading this article
Select an option below:
Go beyond the guidelines
A portal site of complex catheter intervention techniques
About TCROSS NEWS Global

TCROSS NEWS Global is an online medical journal that provides valuable information on Cardiovascular medicine to medical professionals worldwide.
We bring you the latest findings and trends in all areas of cardiovascular medicine. Please register and subscribe for unlimited access to quality Cardiovascular News!

Introducing the main contents
Conference Reports
Conference Reports
Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!
Complex PCI Cases
Complex PCI Cases
Features case reports on patients with complex lesions encountered in daily clinical practice.
Live Demonstration Courses
Live Demonstration CoursesComing soon
In this section you will find live videos of catheter interventions for complex lesions.
What is TCROSS NEWS GLOBAL?
TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Learn more about TCROSS NEWS Global
This website is automatically translated using Google Translate.

Recommendations

Prognostic Utility of Nodular Calcification Detected on Non-Contrast Computed Tomography in Severely Calcified Coronary Lesions
Prognostic Utility of Nodular Calcification Detected on Non-Contrast Computed Tomography in Severely Calcified Coronary Lesions
Circ J
Predictors of Stent Underexpansion After Debulking in Severely Calcified Lesions: A Post Hoc Analysis of the DIRO Trial
Predictors of Stent Underexpansion After Debulking in Severely Calcified Lesions: A Post Hoc Analysis of the DIRO Trial
Circ J
Polypharmacy and Bleeding Outcomes After Percutaneous Coronary Intervention: the CREDO-Kyoto PCI Registry Cohort-3
Polypharmacy and Bleeding Outcomes After Percutaneous Coronary Intervention: the CREDO-Kyoto PCI Registry Cohort-3
Circ J
Prognostic Implications of Fractional Flow Reserve and Coronary Flow Reserve After Drug-Eluting Stent Implantation
Prognostic Implications of Fractional Flow Reserve and Coronary Flow Reserve After Drug-Eluting Stent Implantation
Circ J
PICK UP
Challenging Healthcare Marketing Costs toward Achieving Universal Health Coverage
Special
InsighTCROSS
Outcomes of PCI for CTO in Dialysis Patients: Insights From the Japanese CTO-PCI Expert Registry
CCI
Outcomes of PCI for CTO in Dialysis Patients: Insights From the Japanese CTO-PCI Expert Registry
Association Between Stent-Edge Hinge Motion and Calcified Nodule Formation in Stent-Edge Calcified Coronary Lesions
Circ Intervention
Association Between Stent-Edge Hinge Motion and Calcified Nodule Formation in Stent-Edge Calcified Coronary Lesions
Aspirin-Free Strategy in High Bleeding Risk ACS and Non-ACS Patients Undergoing PCI: A Subgroup Analysis of the STOPDAPT-3 Trial
Circ Intervention
Aspirin-Free Strategy in High Bleeding Risk ACS and Non-ACS Patients Undergoing PCI: A Subgroup Analysis of the STOPDAPT-3 Trial
Digital Twin-Guided Patient Specific Rotor Ablation for Persistent Atrial Fibrillation: The CUVIA Trial
ESC 2025
Digital Twin-Guided Patient Specific Rotor Ablation for Persistent Atrial Fibrillation: The CUVIA Trial